About Us

Who we are

General Biologicals Corporation (GBC), founded in 1984, is a developer and manufacturer of diagnostics and pharmaceutical. We develop high quality in-vitro diagnostics for doctors to make clinical decisions in the area of hepatitis, tumor markers, retro virus, fertility, Thyroid, and Steroids. 
 
In general consumable applications, we provide an anti-bacterial peptide in areas of pharmaceutical, cosmetics, and oral products. 

Our Value

Integrity

We are always honest and open to any feedback or comments we receive to maintain the highest quality of work. Most importantly, we care any unethical issues that may impact the sociality.

Intellection

We strive the best to achieve customers’ goals as well as reaching corporate objectives set by ourselves.

Integration

We integrate our different talents and resources to provide the better experience for our customers to use our products and service.

Innovation

We continue to innovate from products to services with our partners and with our customers.

Our Vision

To be an innovated diagnostics and pharmaceutical company; to create a place where individuals and professionals can access quality products anywhere in the world

Our Leadership

Mr. TC Lin
Chairman & CEO
Mr. Lin serves as the Chairman & CEO at GBC. Mr. Lin was the CEO of Megamedia Corporation for 20 years. Prior to Megamedia, Mr. Lin was involved in various leadership roles at General Instrument of Taiwan Ltd.
Mr. David Hsia
President
University of California, Berkeley,B.A., Biochemistry. Northwestern University, B.S., Medical Technology. 2011-Channel Manager, GE Healthcare. 2013-Chief Operating Officer, Pharmigene, Inc.
Dr. Yin-Peng Chen
V.P. R&D
Ph.D, Molecular and Cellular Biology and Pathology Program; 2009-Focus Diagnostics, Senior Staff Scientist, Healthcare Diagnostics Group. 2012-GenMark Diagnostics, Staff Scientist. 2015-Invivoscribe Technologies, Senior Staff Scientist
Ms. Lancy Chen
VP Translational Medicine
B.S., Department of Pharmacy, China Medical University. Had extensive R&D and manufacturing experiences at Yamanouchi Pharmaceutical Co., Ltd., and Chang Gung Memorial Hospital.
Ms. Cherie Lin
V.P. Healthcare
B.A.in New York University, Master of Business. 10+ Extensive experiences and roles in sales marketing; supervising clinical laboratory and a clinic
Mr. Frank Lin
V.P. Marketing
B.A. in Electrical and Computer Engineering at Purdue University and an MBA at Santa Clara University; co-founded a daily-deal platform Specialdeals.com in 2010. Held technical marketing positions at Matchbin and VeriSilicon, Inc.
Mr. Michael Wu
Special Assistant of Chairman
Master of Medical Engineering. Clinical Science Association – Genzyme, A Sanofi Company. Director of Business Development – Pharmigene. Director of Sales & Marketing – Phalanx
Ding-Shinn Chen, M.D.
Chief Consultant
Foreign Associate, US National Academy of Sciences ; Academician, Academia Sinica Taiwan ; Professor of Medicine, National Taiwan University College of Medicine, Taiwan ; Dean, National Taiwan University College of Medicine, Taiwan

Board of Directors

T.C. Lin

Chairman of GBC
Chairman of CurieMed Corporation

John Hsuan

the Emeritus Vice Chairman of UMC (United Microelectronics Corporation)
Board of Director, GBC

Chung Yu Wang

Chairman, Chinese International Economic Cooperation Association
Board of Director, GBC

Frank Lin, MBA

VP Marketing, Sales at GBC, Board Member at CBA (Chinese Bioscience Association)
Board of Director, GBC

Che Ren Chuang, Ph. D.

Technical Director of SCH Electronic Co., Ltd and Xuhong Biological Technology Co., LTD. (SCH Group)
Independent Director, GBC

Haishan Jang, Ph. D., MBA

Chairman & CEO, BRIM Taiwan
Independent Director, GBC

Johnny Chen, MBA

CEO EverRich Venture Capital
Supervisor, GBC

Chia-Ming Tai

Supervisor, GBC

Hsiang-Huei Kon

Supervisor, GBC

Certification

Quality System